581106-34-5 Usage
Uses
Used in Pharmaceutical Applications:
Phosphonic acid, [3-[acetyl(phenylmethoxy)amino]propyl]-, bis[1-(acetyloxy)ethyl] ester is used as a potential pharmaceutical compound for its unique combination of functional groups. The acetyl and phenylmethoxy groups may contribute to its bioactivity, while the phosphonic acid group could provide a means for chelating or complexing with metal ions, which can be beneficial in the development of new drugs or drug delivery systems.
Used in Industrial Processes:
In industrial applications, Phosphonic acid, [3-[acetyl(phenylmethoxy)amino]propyl]-, bis[1-(acetyloxy)ethyl] ester may be used as a chelating agent or in metal complexation processes. Its strong acid properties and the presence of the phosphonic acid group make it a candidate for use in various chemical reactions or as a component in the synthesis of other compounds.
Used in Chemical Processes:
Phosphonic acid, [3-[acetyl(phenylmethoxy)amino]propyl]-, bis[1-(acetyloxy)ethyl] ester is used as a reagent or intermediate in various chemical processes. The ethyl ester groups may provide solubility and stability in organic solvents, making it suitable for use in synthesis reactions or as a component in the preparation of other complex molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 581106-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,1,1,0 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 581106-34:
(8*5)+(7*8)+(6*1)+(5*1)+(4*0)+(3*6)+(2*3)+(1*4)=135
135 % 10 = 5
So 581106-34-5 is a valid CAS Registry Number.
581106-34-5Relevant academic research and scientific papers
Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity
Ortmann, Regina,Wiesner, Jochen,Reichenberg, Armin,Henschker, Dajana,Beck, Ewald,Jomaa, Hassan,Schlitzer, Martin
, p. 305 - 314 (2007/10/03)
FR900098 represents a derivative of the new antimalarial drug fosmidomycin with enhanced activity. The mechanism of action is the inhibition of the 1-desoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, an essential enzyme of the mevalonate independent
Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity
Ortmann, Regina,Wiesner, Jochen,Reichenberg, Armin,Henschker, Dajana,Beck, Ewald,Jomaa, Hassan,Schlitzer, Martin
, p. 2163 - 2166 (2007/10/03)
FR900098 represents an improved derivative of the new antimalarial drug fosmidomycin and acts through inhibition of the 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, an essential enzyme of the mevalonate independent pathway of isoprenoid biosynt